HOME >> BIOLOGY >> NEWS
Genomic 'firestorms' underlie aggressive breast cancer progression

COLD SPRING HARBOR, N.Y. (Fri., Dec. 1, 2006) -- The first high-resolution analysis of genomic alterations in breast tumors is reported today in the scientific journal Genome Research. In this analysis, scientists from Cold Spring Harbor Laboratory, in collaboration with researchers from Scandinavia, identified three distinct patterns of genomic variation that underlie breast tumor formation, one of which--'firestorms'--may be predictive of aggressive disease progression and short survival.

"'Firestorms' are violent genomic disruptions that lead to destructive forms of breast cancer, even when the rest of the genome is relatively quiet," explains Dr. Jim Hicks, Senior Research Investigator at Cold Spring Harbor Laboratory and lead author on the paper.

Large-scale DNA alterations in cancer cells--rearrangements, deletions, and duplications--may assist in the proliferation and progression of the disease. "A thorough understanding of these changes will allow the design of more rational therapies," says Hicks. "Doctors will be able to recommend an appropriate course of treatment--hormonal therapy or chemotherapy--based on a patient's genomic profile."

Using a high-resolution genomic profiling technique called ROMA (Representational Oligonucleotide Microarray Analysis; see http://www.cshl.edu/public/releases/revealing.html), the scientists tested genomic DNA samples from 243 breast tumor samples acquired from the Karolinska Institute (Sweden) and the Oslo Micrometastasis Study (Norway). The samples were from patients whose clinical history had been documented, which allowed the scientists to associate the genomic profiles with clinical outcomes.

Most strikingly, Hicks and his co-workers found 'firestorms' of genomic amplification--tight chromosomal clusters where DNA segments had undergone multiple rounds of breakage, copying, and rejoining in a c
'"/>

Contact: Maria A. Smit
smit@cshl.edu
516-422-4127
Cold Spring Harbor Laboratory
30-Nov-2006


Page: 1 2

Related biology news :

1. Genomics study provides insight into the evolution of unique human traits
2. Genomic analysis uncovers new targets for HIV vaccine
3. Psychiatric Genomics Center established at Cold Spring Harbor Laboratory
4. Genomic signatures identify targeted therapies for lung cancer
5. NYUs Center for Comparative Functional Genomics part of $57 million MOD-ENCODE consortium
6. Genomic test could help detect radioactivity exposure from terrorist attacks
7. Elsevier launches new journal, Marine Genomics
8. Genomics throws species definition in question for microbes
9. Genomic variation easier to identify with UCSD/Brown software
10. Springer adds Genomic Medicine to biomedical publishing portfolio
11. Genomic comparison of lactic acid bacteria published

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: